Live News EQUITY FLASH L impact Oct 27, 2026, 01:55 PM UTC

SynAct Pharma Signs First Commercial Partnership for Resomelagon

SynAct Pharma has signed its first commercial partnership agreement for resomelagon with a leading Brazilian pharmaceutical company.

SquawkNews Desk 2 updates Updated Oct 27, 2026, 01:58 PM UTC

Story updates

01:58:42 PM UTC

SquawkNews

SynAct Pharma schliesst Partnerschaft mit Hipolabor für Dengue-Therapie in Brasilien SynAct Phar

01:58:43 PM UTC

SquawkNews

SynAct Pharma ingår partnerskap med Hipolabor om resomelagon mot dengue i Brasilien SynAct Pharm